#CRM FOR APPLE MAIL OFFLINE#
Even if the rep shares an IVA with the HCP in offline mode, say during an office visit, Ti CRM captures the usage metadata that maybe used for Closed-Loop Analysis (CLA) to measure the effectiveness of the IVA. And beyond screen sharing slide decks, Ti CRM includes support for Interactive Visual Aids (IVAs) as a standard feature. Reps can hold secure virtual meetings (including video conferencing) with HCPs in a module called QConnect™. What makes Ti CRM compelling, however, is the set of next generation features that are geared toward field reps. Thus, time and cost savings are realized by eliminating duplication of efforts and by leveraging features, services, and data across the platform. Since Ti CRM is interoperable with other applications in the Titanium platform, any data received by any Titanium application is available to all others. QSign™, a purpose-built digital signature solution for business reply cards (BRCs), is available as an add-on to support remote sampling. Ti CRM also comes with a powerful product alignment and highspeed engine that allows clients to exercise controls and limits for reps and HCPs. Ti CRM, as part of QPharma’s Titanium® platform, comes with sampling and compliance features and services that support order processing, sample reconciliation, and signature audits. It may take two to three years for a stable solution to emerge that provides a return on investment.
#CRM FOR APPLE MAIL PROFESSIONAL#
Often the work of implementation is outsourced to a large professional services firm while company’s project managers reassure internal stakeholders and coordinate deliverables from a dozen vendors. Most implementations involve integrating data from multiple sources and managing massive datasets. The technical expertise and project management know-how required to implement a cloud-based CRM solution is daunting for many companies. “And we discovered that current solutions, while feature rich, are often cost prohibitive because of their complexity and long implementation cycles.” “We went through an extensive value curve analysis of the marketplace,” said Suhail Mughal, Chief Technology Officer, QPharma.